Aethlon Medical Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Aethlon Medical Inc.
- Former names
- Bishop Equities Inc
- Ownership
- Public
- Status
- Active
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Nevada
- Headquarters city
- SAN Diego
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- March
- Ticker symbol
- AEMD
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000882291
- EIN
- 13-3632859
- Wikidata ID
- Q4688714
Board of directors
-
Angela Rossetti · DirectorSince 2023
-
Chetan Shah · DirectorSince 2023
-
Edward G. Broenniman · DirectorSince 2023
-
Nicolas Gikakis · DirectorSince 2023
Director election results
Annual meeting of February 19, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
98.3%
-
98.3%
-
98.5%
-
98.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 30, 2026 | Edward G. Broenniman Director | Shares withheld for tax | −1,091 | $0.82 | $895 |
| Jun 30, 2026 | Nicolas Gikakis Director | Shares withheld for tax | −2,182 | $0.82 | $1,789 |
| Jun 30, 2026 | Chetan Shah Director | Shares withheld for tax | −2,182 | $0.82 | $1,789 |
| Apr 17, 2026 | Angela Rossetti Director | Grant or award | +21,815 | $2.29 | $49,956 |
| Apr 17, 2026 | Chetan Shah Director | Grant or award | +21,815 | $2.29 | $49,956 |
| Apr 17, 2026 | Nicolas Gikakis Director | Grant or award | +21,815 | $2.29 | $49,956 |
| Apr 17, 2026 | Edward G. Broenniman Director | Grant or award | +21,815 | $2.29 | $49,956 |
| Mar 31, 2026 | Chetan Shah Director | Shares withheld for tax | −178 | $2.19 | $390 |
| Mar 31, 2026 | Nicolas Gikakis Director | Shares withheld for tax | −178 | $2.19 | $390 |
| Mar 31, 2026 | Edward G. Broenniman Director | Shares withheld for tax | −89 | $2.19 | $195 |
| Dec 31, 2025 | Chetan Shah Director | Shares withheld for tax | −179 | $2.77 | $496 |
| Dec 31, 2025 | Nicolas Gikakis Director | Shares withheld for tax | −179 | $2.77 | $496 |
| Dec 31, 2025 | Edward G. Broenniman Director | Shares withheld for tax | −89 | $2.77 | $247 |
| Sep 30, 2025 | Edward G. Broenniman Director | Shares withheld for tax | −893 | $0.75 | $670 |
| Sep 30, 2025 | Chetan Shah Director | Shares withheld for tax | −1,786 | $0.75 | $1,340 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.